|
| |
| | | 67257 | | 20.01.2020 | | AbbVie AG | | | | | | | | | | | | | 70000. | | | | 07.15. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Rinvoq 15 mg | Retardtabletten | Retard-Tabletten (Upadacitinibum 15 mg) | L04AF03 | PI | | 05 | Rinvoq 30 mg | Retardtabletten | Retard-Tabletten (Upadacitinibum 30 mg) | L04AF03 | PI | | 06 | Rinvoq 45 mg | Retardtabletten | Retard-Tabletten (Upadacitinibum 45 mg) | L04AF03 | PI |
|
|
|
